Brief: TherapeuticsMD Settles U.S. Patent Litigation with Amneal for Bijuva® — Allowing for a May 25, 2032 Generic Entry Date

TherapeuticsMD

08/12/2021 11:53

Dec 8 (Reuters) - TherapeuticsMD Inc  TXMD.O :
    * THERAPEUTICSMD SETTLES U.S. PATENT LITIGATION WITH AMNEAL
FOR
BIJUVA® (ESTRADIOL AND PROGESTERONE) — ALLOWING FOR A MAY 25,
2032 GENERIC ENTRY DATE
    * THERAPEUTICSMD INC - GRANTED TO AMNEAL A LICENSE TO
COMMERCIALIZE AMNEAL'S GENERIC VERSION OF BIJUVA IN UNITED
STATES, COMMENCING ON MAY 25, 2032

Source text for Eikon:  ID:nBw1yRhQza 
Further company coverage:  TXMD.O 

 ((Reuters.Briefs@thomsonreuters.com;;))